Grants Awarded to Young Researchers in Nuclear Medicine

Travel grants have been awarded to five nuclear medicine scientists from Australia, Germany, the Netherlands, and the United States.

The winners of the grants, issued by Eckert & Ziegler Strahlen- und Medizintechnik, AG (Berlin, Germany), were selected by a jury from the European Association of Nuclear Medicine (EANM;) from a total of 534 entries. Work in the fields of oncologic and neurological diagnostic received recognition. The travel grants, which amount to EUR 1,000 each, were presented October 13, 2010, at the annual congress of the EANM in Vienna, Austria, to M. Mustafa, Germany: The impact of SPECT/CT [single photon emission tomography/computed tomography] hybrid imaging in detecting regional lymph node involvement in T1 papillary thyroid carcinoma: presenting an update on a bicentric study including 202 patients; to N. Zarzhevsky, United States: White matter lesions augment cognitive impairments of dopaminergic denervation of the caudate nucleus in Parkinson disease; to T. Aukema, Netherlands: 18F-FDG PET/CT and diagnostic CT for the prediction of histopathologic treatment response after epidermal growth factor receptor tyrosinekinase inhibitor treatment in patients with resectable NSCLC; to J. Beauregard, Australia: The tumoral "Sink Effect” on the biodistribution of 68Ga-octreotate: implications for peptide receptor radionuclide therapy; and to L. Vivash, Australia: The development of [18F]-Flumazenil-PET for localization of the epileptogenic zone in patients with medically refractory focal epilepsy.

"The positron emission tomography [PET] imaging technique is the fastest growing segment on the medical device market. In presenting the EANM Eckert & Ziegler abstract award, we wish to encourage young researchers to present their ideas to a wider audience and to collaborate more in exchanging ideas with other researchers engaged in the field of nuclear medicine. We hope that this will help to ensure that the enormous progress which has been made in medical imaging can soon be transformed into more precise, faster, or cheaper methods of diagnosis and therapy,” explained Dr. Andreas Eckert, CEO of Eckert & Ziegler.

Eckert & Ziegler, AG is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine.

Related Links:
Eckert & Ziegler
European Association of Nuclear Medicine